The Medicine Maker | Interviews

Filter by

Outsourcing Regulation & Standards Biopharma Business & Trends

The Rise of China: From Science Cities to Global Ambition

By James Strachan, Kathryn Wighton

July 15, 2026

Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next

8 min read

The Rise of China: From Science Cities to Global Ambition

Cell & Gene Development & Clinical Business & Trends

Surviving CGT's Funding Winter

By Alun Evans, James Strachan

July 15, 2026

In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market

10 min read

Small Molecules Drug Discovery Development & Clinical

Rewriting the Neuroscience Playbook

By James Strachan

June 23, 2026

Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development

4 min read

Cell & Gene Development & Clinical Interviews

The Scalability Challenge in MSC Therapies

June 12, 2026

John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success

4 min read

The Scalability Challenge in MSC Therapies

Cell & Gene Interviews Business & Trends

Building the Cell Therapy Ecosystem

June 8, 2026

Antoinette Gawin discusses leadership, innovation in blood and cell therapy, and the global systems shaping access to advanced medicine

10 min read

Biopharma Interviews Drug Discovery Development & Clinical

HTC-19 Profile: What’s Cooking in the mRNA Lab?

June 3, 2026

Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking

3 min read